Street Calls of the Week
Investing.com - Truist Securities has raised its price target on RadNet (NASDAQ:RDNT) to $81.00 from $74.00 while maintaining a Buy rating on the stock. According to InvestingPro data, RadNet has shown impressive momentum with a 38% return over the past six months, while analysts maintain a strong buy consensus with price targets ranging from $71 to $80.
The firm cited "robust core imaging center demand trends" alongside various growth opportunities supported by ongoing investments in the Digital Health segment as reasons for the increased target.
Truist Securities noted that both the TechLive rollout and iCAD integration are progressing well, with expectations for continued capacity and efficiency benefits as the Digital Health segment capabilities expand further.
The firm expressed bullishness on RadNet’s scale and market concentration, while also anticipating ongoing de novo activity to aid capacity growth.
Truist Securities views RadNet as "well positioned to augment core trends via opportunistic M&A" according to its research note.
In other recent news, RadNet reported a strong financial performance for the second quarter of 2025, significantly exceeding earnings expectations. The company’s earnings per share (EPS) more than doubled the forecast, while revenue also surpassed expectations. Following this robust performance, Raymond James raised its price target for RadNet from $66 to $75, maintaining a Strong Buy rating. The company’s adjusted EBITDA came in at $81.2 million, surpassing analyst expectations of $77.4 million. Additionally, RadNet’s management increased its adjusted EBITDA guidance by $3 million to a range of $286-296 million, attributing the rise to its core imaging segment. These developments indicate a positive outlook for the company’s financial health, as noted by analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.